Personalized drugs to cure and prevent cancer. BreakBio uses AI to design drugs (peptide vaccines) per patient and then manufacture them per patient.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2019
Main Therapeutic Focus:
Oncology
Lead Product in Development:
Combination therapy including BreakVax cancer vaccine for metastatic colorectal cancer
Development Phase of Primary Product:
Phase I
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
